MSLPQ — MusclePharm Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro Cap

Annual balance sheet for MusclePharm, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	6.23	2.32	1.53	2	1.22
Net Total Accounts Receivable
Net Total Receivables	11.1	6.27	4.81	7.49	6.39
Total Inventory
Prepaid Expenses
Total Current Assets	27.9	22.8	12.2	11.9	11
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.91	0.513	1.39	0.487	0.208
Net Intangible Assets
Other Long Term Assets
Total Assets	30.3	24.6	14.5	13	11.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	28.1	52.6	41.5	32	41.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	47.2	52.8	42.5	37.4	43.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-16.8	-28.2	-28	-24.4	-32.2
Total Liabilities & Shareholders' Equity	30.3	24.6	14.5	13	11.2
Total Common Shares Outstanding